Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am not convinced at all, perhaps a course on Idioms?
I recall the “tip of the iceberg” comment too, he has been great at “picking up” (lol) retail investors with these comments, RWE and peaks at data.
Thank goodness for the likes of Mayo, falconer and the many others (too many to be named) I appreciate for helping me understand the potential of this Company an it’s small molecule pipeline.
Valid concerns, while I agree that Missling has been a good steward of resources, he does have an expensive, world class staff that seemingly has not produced. It is completely fair to question the advancement of company drug approval wise.
Are we meeting with the FDA?
Part of the issue is that we have all
Been jumping to conclusions and manufacturing “what if”
Scenarios all because there isn’t transparent communication and no clarity as to our progress.
Trying to be an “investor”!
Questions for the board:
I have not been to the annual general meeting in the past for various reasons but I would say that I am more interested now than ever, that being said; at the AGM, is there a forum for shareholders to ask questions, if so how much time is allocated to QandA? And when do question have to be submitted for vetting? Have any on this board had questions answered?
I appreciate this board and all of the conversation it stimulates and all of the information shared, I would love to have Anavex accountable to address some of the questions and concerns that are discussed on this board.
Regarding emailing IR, I have done so in the past with no response, perhaps calling direct is a better option.
That’s the problem, they should have a good team, how many ex-FDAers do we have (2)?
What are they doing behind the scenes other than collecting a paycheque and options?
Going back to Misslings psychology as mentioned by a poster recently, missling does not seem to be empowering his team to take an active role in our growth. Criticism of his “one man band” approach are growing stronger!
Thanks again, Sab!
Thank you, Sab!
Really appreciate this info, Sab. Can you tell me how you get this information?
Can you also let me know how may >90% days we have in this downturn?
I am sitting on a lump sum of retirement funds in cash and I am considering deployment and I am hoping to get it invested at or near the bottom of this downturn. I typically don’t try to time the markets but it seems as though this is an opportunity.
I would appreciate any and all feedback from Tom and the rest of the board as well. Sadly, I am ignorant to TA, anything to help my education would be appreciated!
Agreed, if there is a time for strong, definitive statements, now would be a good time. IMO
Enjoy, Fireman! You will be missed
Seconded
Investor, going back to your percentage chance post from a couple weeks/days ago…
20% we had this
50% we may have this
30% we got this
Do you have a revision or update and if so, what is the rational. In simple terms for the simple such as myself.
Please do not see this a facetious, it’s an honest question as I appreciate and respect your opinion. Thank you!
Totally understand that the FDA is in control and I totally agree that it is the about the science and the impact on the indications, I guess my question is more about whether or not Anavex looks to push up review timelines based on the various options that I mentioned or things like FTD or priority review voucher? Or even if they could use those options potentially.
Yes, what are the 2 FDA guys doing???
Question for the board:
Do you think that this communication/ data misunderstanding / hit piece debacle will light a fire under TGD and push him to expedite the approval process for Retts?
Perhaps unblind and use an interim look at Excellence data.
Or perhaps speed up the release of PDD data to further validate MOA?
Or will he just continue on his MO and wait for Excellence/ regular scheduled completion of trials (whenever the hell that will be)?
Agreed, they, and the patients, are the important stakeholders
Not the response I was looking for…
IN RESPONSE TO PUBLIC COMMENTS AND FOR CLARIFICATION:
— Anavex Life Sciences (@AnavexLifeSci) February 1, 2022
The statements made by @adamfeuerstein from @statnews are false and untrue.
Somewhat Bazaar maybe an understatement.
A drop of 20%+ is dramatic, seems to be more that just misunderstanding of data and the drug.
Thank, Phil.
I will review. Exciting times regardless of the share price plummeting over the last 3 months.
Going back to the Rett revenue statement that TGD made referring to back of napkin calculations, he alluded to 2 - 6 billion in revenues (I believe it was in an investor presentation - if anyone knows the source that would be appreciated) , if those predictions are accurate (big question mark) what could we assume the Market cap would be to reflect those revenues. I guess may question is about P/E ratio and industry standards. The Phase 3 change on the clinical trials site is very interesting, encouraging and certainly could explain some of the delays but I dare not get too excited.
It says his cost base was 4.07, I don’t think he left?!
Interesting implications of this!
Maybe June, like last year?
I hope he is getting the message, I understand that these trials take time and that there are delays as a result of covid other variables etc but tell me when has he once met a self imposed deadline and why does he not change the way he communicates timelines etc. Has he not heard of under promise and over deliver. While I believe that market rotation etc is part of the reason for this share price decline I also believe that Missling’s delays in releasing info has compounded the general decline in the biotech sector.
Board response: he has a higher purpose
I love how we outpace the XBI. I also love bloodbaths based on no bad news
Too late just bought more, lol
Huge drop at the beginning of Dec as well
Thanks, on now
He is referring to adagio, he was responding to Sabs post.
I can’t wait for the AGM this year!
Lot of discontent out there right now, I
Wonder if something will change the sentiment between then and now?
The PDD OLE is what I want to see! How much observation time in OLE would there be now?
Honestly, I was somewhat offended by the laugh. I felt like it was dismissive in tone and showed a lack of tact. We all understand the reason for the question…. As he is continuously missing self imposed deadlines/targets. If he wasn’t always off on his time estimations there would be no need for a question like that. That being said, I was happy he laughed as it almost confirms that results for Avatar will be released “soon”
Fraud is right
By definition Scotch is distilled, and aged in Scotland
The problem: words have meaning
Canadian Rye whiskey (that cheap yet delicious grain) does not even have to be made from rye anymore
Which leads leads to the ethical question:
Blended versus single malt
I know where I stand
Connecting dots, one might say!
Thank you, I always mix up the 2. Perhaps because I feel the paediatric trail is more important and subconsciously I see Avatar as a more important/meaningful name. My own idiosyncrasies
This is interesting, thank you for posting it. What would the conference be looking for in an abstract, would excellence data be the key to acceptance or could some other data/info/presentation be worthwhile to offer? I understand all of this would be your opinion of course.
Why, do you think, they PR some conferences but not others? In this case is it because they are always at HC Wainwright?
I think the key difference with the Retts and Alzheimer’s trials is that they PRd when the last trial participants were enrolled in the Alzheimer’s trial.
To the best of my knowledge/recollection they have not PRd the last participants enrolment in Avatar or excellence. That indicates to me that they have less excuse/reason to drag out the Alzheimers trial results.
Seems that way, what is the reason(s), do you think?
Frrol, I do appreciate your posts, you are a good counterbalance but these petty attacks are not a good look on you and diminish any creditably you have.